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Abstract
Background: To evaluate factors associated with whether patients associate their fracture with
future fracture risk.
Methods: Fragility fracture patients participated in a telephone interview. Unadjusted odds ratios
(OR, [95% CI]) were calculated to identify factors associated with whether patients associate their
fracture with increased fracture risk or osteoporosis. Predictors identified in univariate analysis
were entered into multivariable logistic regression models.
Results: 127 fragility fracture patients (82% female) participated in the study, mean (SD) age 67.5
(12.7) years. An osteoporosis diagnosis was reported in 56 (44%) participants, but only 17%
thought their fracture was related to osteoporosis. Less than 50% perceived themselves at
increased risk of fracture. The odds of an individual perceiving themselves at increased risk for
fracture were higher for those that reported a diagnosis of osteoporosis (OR 22.91 [95%CI
7.45;70.44], p < 0.001), but the odds decreased with increasing age (0.95 [0.91;0.99], p<0.009). The
only variable significantly associated with the perception that the fracture was related to
osteoporosis was self-reported osteoporosis diagnosis (39.83 [8.15;194.71], p<0.001).
Conclusion: Many fragility fracture patients do not associate their fracture with osteoporosis. It
is crucial for physicians to communicate to patients that an osteoporosis diagnosis, increasing age
or a fragility fracture increases the risk for future fracture.
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Background
Osteoporosis has been described as a silent disease until
an individual experiences a fragility fracture. A fragility
fracture is a fracture that occurs with minimal trauma,
such as a fall from a standing height or less. In Canada,
age-adjusted incidence rates for hip fracture in 1993–4
were 479 per 100 000 for women and 187 per 100 000 for
men, and have been projected to increase four-fold by
2041, and the annual cost of care were estimated at $650
million dollars in 2001 [1,2]. Not only do fragility frac-
tures impose an economic burden, but also there are
human costs; fragility fractures can reduce quality of life,
increase fear of falling, and often result in impaired
mobility and a loss of independence [3-5]. Therapeutic
options can reduce the number of new vertebral compres-
sion fractures by 40–60% within the first year in individ-
uals with a fracture [6]. For example, the relative risk of
fracture associated with alendronate use compared with
placebo in women with osteoporosis is 0.47 (95% confi-
dence intervals 0.26–0.79) for hip fractures, 0.52
(0.42–0.66) for radiographic vertebral fractures and 0.70
(0.59–0.82) for all clinical fractures [7]. Increasing age
and a history of fragility fracture are independent predic-
tors of subsequent fracture [8]. Therefore, it is essential
that individuals who experience fragility fracture be
assessed and treated for osteoporosis. However, individu-
als over the age of 40 years with fragility fracture are not
receiving appropriate osteoporosis management [9,10].
If patients do not link their fractures with having a disease,
and are not aware that they can actively participate in the
disease evolution, then the opportunity to prevent future
fractures may be lost [11]. In-depth interviews reveal that
many patients with fragility fracture had not associated
their fracture with bone fragility. Instead they attributed
their fractures to external factors, such as a fall, or slipping
on ice [12-14]. In fact, for some patients the belief that
their fracture was an accident was so strong that even sub-
sequent fractures were attributed to external situations
rather than bone fragility. A survey of peri- and postmen-
opausal women revealed that although the majority of
women (89%) perceived osteoporosis a serious condi-
tion, only 29% thought they might be susceptible, and
they were less concerned about osteoporosis when com-
pared to cancer, even though the health consequences of
osteoporosis are at least equal to that of breast cancer
[12,13,15]. With a chronic disease such as osteoporosis,
patient self-management is an important component to
effective long-term management, especially with self-care
issues such as adequate calcium and vitamin D intakes,
fall prevention and exercise [16]. There is also a need for
long-term adherence to prescribed therapies and self-
management. Therefore, it is essential that patients under-
stand that having a fragility fracture increases their risk for
subsequent fractures, and that preventative action may be
necessary.
Although previous studies have evaluated whether peri-
and postmenopausal women and women with fractures
perceive their fracture to be related to osteoporosis
[12,13,15], it is not known whether fragility fracture
patients understand that they are at increased risk of
future fracture. Further, no study has evaluated factors,
such as age, gender or diagnosis of osteoporosis that may
be associated with perceived susceptibility to subsequent
fractures in fragility fracture patients. The purpose of the
current study was to evaluate whether patients with a fra-
gility fracture perceive themselves to be at risk of future
fracture, and to identify factors associated with whether a
fragility fracture patient perceives themselves to be at risk
of future fractures.
Methods
Participants
Patients treated for a fracture by orthopaedic surgeons at
two major teaching hospital fracture clinics were con-
tacted. Fractures had to occur at the radius, humerus,
femur, rib, tibia (in females only), pelvis or vertebrae to be
considered a possible osteoporotic fracture [17]. All
patients who had had a fracture at specified sites 2 years
prior were identified by orthopaedic surgeons' records,
and contacted by the study team. Participants were con-
sidered eligible for inclusion in the study if they were 40
years of age or older and if they had experienced a fragility
fracture within 18 months of the interview date. Inter-
views were conducted from September 2005 to June 2006.
Exclusion criteria were as follows: fractures of the hands,
feet, skull, clavicle, ankle or the tibia in males; fracture due
to malignancy; non-fragility fractures; not living in the
community; not able to communicate in English; on dial-
ysis; unable to complete interview due to memory loss,
dementia or other medical reasons; fracture > 2 years prior
to avoid problems with recall (Figure 1). Patients were
also asked to describe the incident in which the fracture
occurred to verify whether the fracture was a fragility frac-
ture. The study received approval by the Hamilton Health
Sciences Research Ethics Board and the St. Joseph's
Healthcare Research Ethics Board.
Survey
A structured telephone interview was conducted with
individuals who agreed to participate using a survey
instrument developed and pilot-tested for this study by
the research team. The interview contained questions
about the following: socio-demographic information;
prescription medication use in the past year (including
treatments for osteoporosis, calcium and vitamin D sup-
plementation); medical and fracture history; family his-
tory of osteoporosis; participation in osteoporosisBMC Musculoskeletal Disorders 2008, 9:38 http://www.biomedcentral.com/1471-2474/9/38
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preventative activities (e.g. exercise, intake of calcium rich
foods, fall prevention); and participant perceptions about
their risk of fracture.
To determine whether individuals who had had a fragility
fracture understood what osteoporosis was, whether they
associated their fractures with osteoporosis or perceived
themselves at risk for future fracture, the following ques-
tions were included in the survey: 1) Do you think that
breaking your (insert site of fracture here) means that you
are at risk for breaking a bone in the future?; 2) Do you
think your fracture was related to osteoporosis?; 3) Do
you know what osteoporosis is?; and 4) If yes to question 3:
What do you think it is?. Possible responses to questions
1–3 were "yes", "no" and "unsure". Question 4 was
included to confirm whether their understanding of oste-
Flow diagram of participant recruitment and inclusion/exclusion Figure 1
Flow diagram of participant recruitment and inclusion/exclusion.
Potential Participant Pool: 738 
443
259
127
Individuals screened and excluded: 295 
Living in long-term care: 96 
Deceased: 49 
< 40 years of age: 16 
Non-fragility fractures: 37 
Fracture prior to November 2003: 10 
Fracture possibly due to malignancy: 11 
Error in record, no actual fracture: 7 
Alzheimer's disease: 2 
Dialysis: 3 
Parkinson’s disease: 2 
Duplicates: 6 
Unable to communicate in English: 38 
Other: 18 
Individuals choosing not to participate: 184 
Hard of hearing (unable to hear during phone 
conversation): 7 
Participant felt they were too old: 5 
Participant described themselves as 'not well': 8 
Participant will be away at time of interview: 7 
No time/too busy: 6
Decline to continue during interview: 7 
Not willing to participate/Other: 144
Individuals who could not be contacted after 
multiple attempts: 132 
Individuals included in the study: 127 BMC Musculoskeletal Disorders 2008, 9:38 http://www.biomedcentral.com/1471-2474/9/38
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oporosis was accurate, and responses were qualitative in
nature.
Statistical Analyses
Descriptive statistics for demographic and clinical partici-
pant characteristics are presented as mean (standard devi-
ation [SD]) for continuous variables or count (percent)
for categorical variables. The sample size was based on
building a stable multivariable model. Simulation studies
demonstrate that logistic models require 10 to 15 events
per predictor to produce stable estimates [18,19]. We
hypothesized that 40% of respondents would associate
their current fracture with the potential for future frac-
tures. Therefore, 125 respondents would be required to fit
a model with 3–5 predictors. There were no missing data.
For the questions pertaining to perceptions of risk (ques-
tions 1 and 3 above), two separate analyses were per-
formed; 1) the response "unsure" was coded as "no"; and
2) the response "unsure" was coded as missing. The fol-
lowing demographic and health-related variables were
considered as potential correlates of patients' perceptions
of risk: age, gender, education, marital status, living
arrangements, site of index fracture, history of a previous
fracture, family history of fracture at wrist, spine or hip
after the age of 40, use of an assistive aid, ever being told
they have osteoporosis, being on an osteoporosis medica-
tion, having experienced a loss of height and number of
medications. Variables were selected for hypothesis-gen-
erating purposes.
Unadjusted odds ratios (OR) and 95% confidence inter-
vals were calculated to identify factors associated with
whether patients associated their fracture with being at
risk of future fracture, or associated their fracture with
osteoporosis. To be conservative, predictors found to be
statistically significant at alpha = 0.20 in univariate analy-
sis were entered into multivariable logistic regression
models to identify factors that are associated with whether
patients associate fragility fracture with and increased risk
of future fracture, or with osteoporosis. When two varia-
bles that exhibited collinearity were both significant in
univariate analyses, only one was included, and the one
chosen was based on clinical relevance. We examined the
residuals to assess model assumptions. Goodness-of-fit
for the models was performed using the Hosmer-Leme-
show test [20]. Data were managed and analyzed using
SPSS® software (Version 15.0), and all statistical tests were
two-sided. The criterion for statistical significance was set
at alpha = 0.05.
Results
The mean (SD) age of the entire cohort approached was
71.8 years (16.3), where 73.3% were female. The response
rate for the telephone interview was 29% (Figure 1) with
127 responding. Demographic characteristics of the 127
participants are listed in Table 1. Females represented
82% (106/127) of the sample. The mean (SD) age was
67.5 (12.7) years. A history of a previous fracture after the
age of 40 years was reported by 51 (40%) participants,
including 16 wrist fractures, 2 hip fractures, 2 pelvis frac-
tures, 2 spine fractures, 6 humerus fractures, 6 ankle frac-
tures and 25 fractures reported at other sites. A diagnosis
of osteoporosis was reported in 56 (44%) participants.
Among those with an osteoporosis diagnosis, 45 (80%)
were diagnosed before the index fracture. Use of at least
one medication, not including supplements, for oste-
oporosis was reported in 54 (43%) individuals.
Perceptions of osteoporosis and fracture risk
Over 40% of individuals who had suffered a fragility frac-
ture perceived themselves to be at increased risk of future
fracture (Table 2). Despite the fact that 44% of respond-
ents had been told that they have osteoporosis, only 17%
of respondents thought their fracture was related to oste-
oporosis (Table 2), 54% of respondents did not think
their fracture was related to osteoporosis and a relatively
large proportion of respondents were unsure whether
their fracture was related to osteoporosis (29%). Among
those that thought their fracture was related to osteoporo-
sis, almost all (20/22) had been told they have osteoporo-
sis. Most of the sample (91%, or n = 115) reported that
they knew what osteoporosis was. Among respondents
who indicated that they did know what osteoporosis was,
the responses were as follows: 95 (75%) respondents
reported that it resulted in bone loss or calcium loss,
weakening/thinning of the bones or bones becoming
porous, 6 (5%) respondents reported only that it was a
disease of the bones, 4 (3%) respondents reported that it
was crippling or resulted in a crooked spine but did not
refer to a disease of bones, 5 (4%) respondents gave an
incorrect response but it was related to bones (e.g. loss of
bone marrow), 5 (4%) respondents gave an answer
related to arthritis or other definition unrelated to oste-
oporosis or bones. The remaining 12 (9%) respondents
reported that they did not know what osteoporosis was or
were unsure.
Logistic Regression Analysis Results
In multivariable analyses, certain variables were signifi-
cantly related to an individual perceiving that having a
fracture meant that they were at increased risk of future
fracture (Table 3). The odds of an individual responding
"yes" to the question "Do you think that breaking your
(wrist, hip, etc) means that you are at increased risk for
breaking a bone in the future?" were higher for those that
reported a diagnosis of osteoporosis (OR 22.91 [95%CI
7.45;70.44], p < 0.001), but the odds decreased with
increasing age (0.95 [0.91;0.99], p < 0.009). When the
response "unsure" was coded as "no", the odds ratiosBMC Musculoskeletal Disorders 2008, 9:38 http://www.biomedcentral.com/1471-2474/9/38
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associated with a "yes" response associated with having a
diagnosis of osteoporosis and increasing age were 14.92
(5.63;39.58) p < 0.001, and 0.94 (0.91;0.98), p < 0.003,
respectively. For the question "Do you think that your
fracture was related to osteoporosis?" the only variable
that remained significantly related to a "yes" response in
multivariable analyses was if the individual had ever been
told they have osteoporosis (39.83 [8.15;194.71], p <
0.001).
Discussion
The current study demonstrates that a substantial number
of individuals who suffer a fragility fracture do not per-
ceive themselves to be at increased risk for future fracture,
and an even greater number of individuals do not associ-
ate their fracture with osteoporosis. The odds that individ-
uals perceived themselves at risk for future fracture were
higher among individuals who had been told that they
had osteoporosis, but decreased with increasing age. If
individuals with fragility fracture do not perceive them-
selves at risk for future fracture, they may be less likely to
Table 1: Participant Characteristics
Total Number of Participants 127
Age in years (SD) 67.5 (12.7)
Number of Females: n (%) 106 (82)
Menopausal Status (females): n (%)
Pre-menopausal 4 (3.1)
Peri-menopausal 3 (2.3)
Post-menopausal 95 (74.8)
Unsure 3 (2.3)
Site of Index Fracture: n (%)
wrist 72 (56.7)
hip 26 (20.5)
other femur fracture 10 (7.9)
humerus 5 (3.9)
spine 1 (0.8)
pelvis 1 (0.8)
elbow 12 (9.4)
Cause of fracture: n (%)
Fall from standing height 75 (59.1)
Twisting 3 (2.4)
Slipping on ice 37 (29.1)
Ice skating 3 (2.4)
Re-fracture 1 (0.8)
Fall from standing height while running 2 (1.6)
Hit it on something 2 (1.6)
Unsure 1 (0.8)
Spontaneous 3 (2.4)
Average time post-fracture in months (SD) 11.2 (6.3)
History of previous fracture: n (%) 51 (40.2)
Family history of fracture: n (%) 28 (21.7)
Self-reported height loss: n (%) 67 (51.9)
At least one fall in the past year*: n (%) 103 (81.1)
3 or more falls in the past year: n (%) 13 (10.1)
Use assistive aid for mobility (cane, crutches, walker, wheelchair): n (%) 45 (35.4)
4 or more prescription medications: n (%) 53 (41.1)
Average number of prescription medications: Mean (SD) 3.7 (3.3)
Marital Status: n (%)
Single 7 (5.4)
Married 67 (52.8)
Widowed 34 (26.4)
Divorced/Separated 19 (14.7)
Living arrangements: n (%)
Live alone 45 (34.9)
Live with others 82 (64.6)
*if the respondent's fracture was due to a fall, this fall was included in the totalBMC Musculoskeletal Disorders 2008, 9:38 http://www.biomedcentral.com/1471-2474/9/38
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accept or adhere to recommended treatment [11,21],
which may partially explain the reports of poor manage-
ment among this patient group. Recent systematic reviews
have demonstrated that in Canada and internationally,
individuals who suffer fragility fractures are not receiving
adequate osteoporosis management [9,10].
Perceived susceptibility to osteoporosis has been evalu-
ated among community-based women over the age of 40
who had not been diagnosed with osteoporosis; the
majority of women perceive their risk to be lower than
other women their age, and they attributed their lower
risk primarily to their own preventative behaviours [22].
The current study is unique because it evaluated perceived
risk of fracture among community-living individuals who
had recently suffered a fragility fracture and are therefore
at higher risk of future fracture than individuals who have
not had a fracture. However, even among this higher risk
group, many individuals with a prior fragility fracture still
do not perceive an increased susceptibility to future frac-
ture. Perceived risk of future fracture decreased with
increasing age among fragility fracture patients, which is
alarming considering that increasing age and a history of
fracture are both independent predictors of subsequent
fracture [8]. Further, it has been demonstrated that older
individuals with fragility fracture are not prescribed oste-
oporosis treatment as often as younger individuals [9]. A
negative relationship between perceived risk of chronic
diseases (i.e. osteoporosis, breast cancer and heart dis-
ease) and age has been demonstrated previously among
community-living individuals [23,24]. It has been sug-
gested that women may perceive themselves to be less sus-
ceptible to osteoporosis with age because the longer they
live without experiencing the disease, the more distant the
threat of the disease appears, the more likely they are to
perceive the disease occurrence to be low, or the more dis-
similar they view themselves to women with the disease
[24]. However, the participants in the current study have
already experienced a consequence of osteoporosis,
namely, a fragility fracture. It appears many individuals
do not recognize their fracture is an indicator that they are
at risk for osteoporosis and future fractures. Therefore, it is
crucial to communicate to individuals who have suffered
Table 2: Responses of individuals who have had a fragility fracture to questions about their perceptions of osteoporosis and fracture 
risk (n = 127)
Response: Number of Respondents (%)
YES NO UNSURE
Do you think that breaking your (insert fracture site) means that you are at increased risk of 
breaking a bone in the future?
55 (43.3) 53 (41.7) 19 (15)
Do you think your fracture was related to osteoporosis? 22 (17.3) 68 (53.5) 37 (29.1)
Have you ever been told that you have osteoporosis? 56 (44.1) 67 (52.8) 4 (3.1)
Do you know what osteoporosis is? 115 (90.6) 11 (8.7) 1 (0.8)
Table 3: Estimated odds ratios (95% CIs) for variables associated with perceiving that a fragility fracture results in an increased risk of 
future fracture, or that the fragility fracture is related to osteoporosis.
Question Variable (reference) OR (95% C.I.) p-value
Do you think that breaking your (insert fracture site) means that you are at 
increased risk of breaking a bone in the future? (unsure coded as missing, n 
= 108)
Ever told you have osteoporosis (No) 22.91 (7.45; 70.44) 0.001
Age (per year) 0.95 (0.91;0.99) 0.009
Sex (male) 1.41 (0.332;6.00) 0.640
Do you think that breaking your (insert fracture site) means that you are at 
increased risk of breaking a bone in the future? (unsure coded as no, n = 
127)
Ever told you have osteoporosis (No) 14.93 (5.63;39.58) 0.001
Age (per year) 0.94 (0.91;0.98) 0.003
Sex (male) 2.23 (0.58;8.57) 0.244
Do you think that your fracture was related to osteoporosis? (unsure 
coded as missing, n = 90)
Ever told you have osteoporosis (No) 39.83 (8.15;194.71) 0.001
Use an assistive aid (No) 2.43 (0.65;9.03) 0.185
Do you think that your fracture was related to osteoporosis? (unsure 
coded as no, n = 127)
Ever told you have osteoporosis (No) 18.10 (3.98;82.27) 0.001
Use an assistive aid (No) 1.52 (0.54;4.25) 0.426BMC Musculoskeletal Disorders 2008, 9:38 http://www.biomedcentral.com/1471-2474/9/38
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a fragility fracture that they may have osteoporosis and are
at increased risk of future fractures [8].
The likelihood that a patient with a fragility fracture per-
ceived themselves to be at increased risk of future fracture
was much greater if they had been told that they had oste-
oporosis. However, the clear communication of an oste-
oporosis diagnosis to fragility fracture patients is
inconsistent, and there is a care gap between the occur-
rence of a fragility fracture and osteoporosis diagnosis and
treatment [9,10,25]. Interestingly, the current study dem-
onstrated that only about one in five individuals thought
their fracture was related to osteoporosis. This is particu-
larly concerning considering that almost half of the sam-
ple had been given a diagnosis of osteoporosis, and 80%
of those were diagnosed before  the index fracture. The
results of the current study suggest that patients may not
understand that osteoporosis leads to an increased risk of
future fracture, that there is a lack of understanding of
what osteoporosis is, or that patients do not associate hav-
ing a fragility fracture with having a chronic disease,
namely osteoporosis.
A recent study demonstrated that perceived susceptibility
to osteoporosis was related to current use of antiresorptive
medication [11]. Similarly, that having a previous bone
density test or diagnosis of osteoporosis were the only fac-
tors associated with active consideration of or current use
of osteoporosis medication in hip fracture patients [21].
Therefore, communicating to patients that having a fragil-
ity fracture increases their susceptibility to future fracture
may be crucial for increasing the probability that patients
will accept osteoporosis therapy and participate in
chronic disease management. It has been demonstrated
that if women had an understanding of the impact of a
self-management behaviour (i.e. calcium intake) related
to osteoporosis they were more likely to act on that
knowledge [26]. Self-management is an important com-
ponent of chronic disease management; a recent meta-
analysis revealed that self-management programs for dia-
betes mellitus and hypertension produced statistically
and clinically significant benefits [27]. A patient-centred
approach targeting the patient's perception of future frac-
ture risk may be a critical element in improving oste-
oporosis management. In a prospective study, providing
women with a decision aid about benefits and risks of
hormone therapy, educational tools and feedback about
densitometry resulted in increased use of osteoporosis
medications, including calcium and vitamin D [28]. A
recent quasi-experimental non-randomized trial demon-
strated that patient education in addition to informing the
physician of the fracture and providing treatment guide-
lines significantly improved both osteoporosis investiga-
tion and treatment rates, resulted in improved persistence
with therapy and was cost-saving [29,30]. Further, the
method of communication may be crucial. For example, a
recent study demonstrated that patients preferred simple
bar charts with absolute lifetime risk depicted on them
[31].
The current study has a few limitations. Among the poten-
tial pool of participants, 42% chose not to participate and
30% could not be contacted to determine if they were eli-
gible. We do not have bone density data to confirm
whether all participants have osteoporosis. However, hav-
ing a fragility fracture is a predictor of future fractures
independent of bone density [8]. We report history of
prior fracture after the age of 40, but we did not ascertain
whether prior fractures were also fragility fractures. The
proportion of respondents reporting a diagnosis of oste-
oporosis is relatively high compared to previous reports of
the proportion of fragility fracture patients diagnosed
with osteoporosis after fracture [9,10], suggesting that we
may have over-represented individuals with diagnosed
osteoporosis. However, even among our sample there
were a substantial number of individuals who did not
make the link between their fragility fracture and oste-
oporosis. Given the observed relationship between having
an osteoporosis diagnosis and perception of future frac-
ture risk in the current sample, inclusion of a more repre-
sentative sample may have actually increased the strength
of our findings.
Conclusion
In summary, many individuals who suffer fragility frac-
ture do not associate their fracture with osteoporosis.
Communicating a diagnosis of osteoporosis to the patient
was strongly related to perceptions of future fracture risk,
as was age. It is crucial for health care providers to com-
municate to the patient that increasing age and having a
fragility fracture increases the risk for future fracture, so
that patients can become active participants in chronic
disease management. It may also be necessary to rethink
the way we convey messages about fracture risk to
patients; rather than relying on brief verbal communica-
tions between patient and physician during follow-up vis-
its, the message could be emphasized using well designed
written materials that include attention-grabbing graph-
ics. As well the message that fragility fracture equals risk of
future fragility fracture needs to become part of a nation-
wide post-fracture care initiative that targets patients in
hospital so that all patients are made aware of the risk.
Future research should investigate whether risk percep-
tions or a diagnosis of osteoporosis influences acceptance
of or adherence to recommended therapies, or the impact
of patient-centred educational interventions on the
patient's perception of risk.BMC Musculoskeletal Disorders 2008, 9:38 http://www.biomedcentral.com/1471-2474/9/38
Page 8 of 9
(page number not for citation purposes)
Competing interests
J.D. Adachi
I have been involved in clinical trials with the following
companies: Amgen, Eli Lilly, Glaxo Smith Kline, Merck
Frosst, Novartis, NPS-Allelix, Pfizer, Procter & Gamble,
Roche, Sanofi Aventis, Wyeth. I have been a consultant to:
Amgen, Astra Zeneca, Eli Lilly, Glaxo Smith Kline, Merck
Frosst, Novartis, Pfizer, Procter & Gamble, Roche, Sanofi
Aventis, Servier, Wyeth.
A. Cranney
I have been involved in clinical trials with Eli Lilly and
Zelos Therapeutics and received honoraria for speaking
from Novartis, Procter & Gamble and Merck Frosst.
A. Papaioannou
I am or have been a consultant or on the speaker's bureau
for the following: Aventis Pharma, Eli Lilly Canada Inc.,
Merck Frosst Canada, Novartis Pharmaceticals Canada
Inc., Proctor and Gamble Pharmaceuticals.
L. Dolovich
I have been a co-investigator on research grants supported
by Aventis, Eli Lilly and Merck Frosst.
L. Giangregorio
I have been a co-investigator on a research grant sup-
ported by Merck Frosst.
L. Thabane, J. deBeer, A. Adili
Nothing to disclose
Authors' contributions
LG and AP conceived of the research questions and devel-
oped the initial proposal. LG, AP, JDA, LD and AC con-
ceived of the final proposal, including study design,
methods and literature review, funded by the Drummond
Foundation. LG, AP, JDA, LD, AC and LT developed and
pilot tested the telephone survey. JD, AA and LG were
responsible for developing and implementing the partici-
pant recruitment and screening process, and data acquisi-
tion. LG and LT performed data analysis. JD, AA, JDA, AC
and AP contributed clinical expertise with respect to sur-
vey development, data analysis and data interpretation.
LG was primarily responsible for writing the initial draft
of the manuscript, but all authors contributed to and
approved subsequent revisions.
Acknowledgements
The authors would like to acknowledge financial support from The Drum-
mond Foundation. A. Cranney holds a research salary award from the 
Canadian Institutes of Health Research. J.D. Adachi holds the Alliance for 
Better Bone Health Chair in Rheumatology, funded by the Alliance of 
Procter & Gamble and Sanofi Aventis. The authors had full access to all of 
the data in the study and take responsibility for the integrity of the data and 
the accuracy of the data analysis. This project was part of the "Fracture? 
Think Osteoporosis!" initiative at Hamilton Health Sciences. We would like 
to thank the orthopaedic surgeons at the Henderson Hospital and St. 
Joseph's Healthcare for their assistance: Dr. Mitchell Winemaker, Dr. 
David Wismer, Dr. Nigel Colterjohn, Dr. Brett Dunlop, Dr. Jaydeep Moro 
and Dr. Arthur Porte. We also acknowledge the assistance of Madeline 
Nixon, Jennifer Ranford, Ruth McCallum, and Katherine Gaebel in the 
recruitment, screening and interviewing of study participants.
References
1. Papadimitropoulos EA, Coyte PC, Josse RG, Greenwood CE: Cur-
rent and projected rates of hip fracture in Canada.  CMAJ
1997, 157:1357-1363.
2. Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitro-
poulos E: Economic implications of hip fracture: health serv-
ice use, institutional care and cost in Canada.  Osteoporos Int
2001, 12:271-278.
3. Petrella RJ, Payne M, Myers A, Overend T, Chesworth B: Physical
function and fear of falling after hip fracture rehabilitation in
the elderly.  Am J Phys Med Rehabil 2000, 79:154-160.
4. Adachi JD, Loannidis G, Berger C, Joseph L, Papaioannou A, Pickard
L, Papadimitropoulos EA, Hopman W, Poliquin S, Prior JC, Hanley
DA, Olszynski WP, Anastassiades T, Brown JP, Murray T, Jackson SA,
Tenenhouse A: The influence of osteoporotic fractures on
health-related quality of life in community-dwelling men and
women across Canada.  Osteoporos Int 2001, 12:903-908.
5. Papaioannou A, Watts NB, Kendler DL, Yuen CK, Adachi JD, Ferko
N: Diagnosis and management of vertebral fractures in eld-
erly adults.  Am J Med 2002, 113:220-228.
6. Brown JP, Josse RG: 2002 clinical practice guidelines for the
diagnosis and management of osteoporosis in Canada.  CMAJ
2002, 167:S1-34.
7. Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg
MC, Nevitt MC, Suryawanshi S, Cummings SR: Fracture risk reduc-
tion with alendronate in women with osteoporosis: the Frac-
ture Intervention Trial. FIT Research Group.  J Clin Endocrinol
Metab 2000, 85:4118-4124.
8. Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eis-
man J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D,
Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A: A meta-analy-
sis of previous fracture and subsequent fracture risk.  Bone
2004, 35:375-382.
9. Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD:
Fragility fractures and the osteoporosis care gap: an interna-
tional phenomenon.  Semin Arthritis Rheum 2006, 35:293-305.
10. Papaioannou A, Giangregorio L, Kvern B, Boulos P, Ioannidis G,
Adachi JD: The osteoporosis care gap in Canada.  BMC Muscu-
loskelet Disord 2004, 5:11.
11. Cline RR, Farley JF, Hansen RA, Schommer JC: Osteoporosis
beliefs and antiresorptive medication use.  Maturitas 2005,
50:196-208.
12. Meadows LM, Mrkonjic LA, Lagendyk LE, Petersen KM: After the
fall: women's views of fractures in relation to bone health at
midlife.  Women Health 2004, 39:47-62.
13. Meadows LM, Mrkonjic LA: Breaking--bad news: women's expe-
riences of fractures at midlife.  Can J Public Health 2003,
94:427-430.
14. Reventlow S, Bang H: Brittle bones: ageing or threat of disease
exploring women's cultural models of osteoporosis.  Scand J
Public Health 2006, 34:320-326.
15. Hsieh C, Novielli KD, Diamond JJ, Cheruva D: Health beliefs and
attitudes toward the prevention of osteoporosis in older
women.  Menopause 2001, 8:372-376.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Musculoskeletal Disorders 2008, 9:38 http://www.biomedcentral.com/1471-2474/9/38
Page 9 of 9
(page number not for citation purposes)
16. Holman H, Lorig K: Patient self-management: a key to effec-
tiveness and efficiency in care of chronic disease.  Public Health
Rep 2004, 119:239-243.
17. Kanis JA, Oden A, Johnell O, Jonsson B, De Laet C, Dawson A: The
burden of osteoporotic fractures: a method for setting inter-
vention thresholds.  Osteoporos Int 2001, 12:417-427.
18. Babyak MA: What you see may not be what you get: a brief,
nontechnical introduction to overfitting in regression-type
models.  Psychosom Med 2004, 66:411-421.
19. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR: A simu-
lation study of the number of events per variable in logistic
regression analysis.  J Clin Epidemiol 1996, 49:1373-1379.
20. Hosmer DW, S L: Applied Logistic Regression Edited by: Inc JWS. New
York; 1989. 
21. Mauck KF, Cuddihy MT, Trousdale RT, Pond GR, Pankratz VS, Melton
LJ III: The decision to accept treatment for osteoporosis fol-
lowing hip fracture: exploring the woman's perspective using
a stage-of-change model.  Osteoporos Int 2002, 13:560-564.
22. Gerend MA, Erchull MJ, Aiken LS, Maner JK: Reasons and risk: fac-
tors underlying women's perceptions of susceptibility to
osteoporosis.  Maturitas 2006, 55:227-237.
23. Phillipov G, Phillips PJ, Leach G, Taylor AW: Public perceptions
and self-reported prevalence of osteoporosis in South Aus-
tralia.  Osteoporos Int 1998, 8:552-556.
24. Gerend MA, Aiken LS, West SG, Erchull MJ: Beyond medical risk:
investigating the psychological factors underlying women's
perceptions of susceptibility to breast cancer, heart disease,
and osteoporosis.  Health Psychol 2004, 23:247-258.
25. Meadows LM, Mrkonjic LA, O'brien MD, Tink W: The importance
of communication in secondary fragility fracture treatment
and prevention.  Osteoporos Int 2007, 18:159-166.
26. Satterfield T, Johnson SM, Slovic P, Neil N, Schein JR: Perceived
risks and reported behaviors associated with osteoporosis
and its treatment.  Women Health 2000, 31:21-40.
27. Chodosh J, Morton SC, Mojica W, Maglione M, Suttorp MJ, Hilton L,
Rhodes S, Shekelle P: Meta-analysis: chronic disease self-man-
agement programs for older adults.  Ann Intern Med 2005,
143:427-438.
28. Papaioannou A, Parkinson W, Adachi J, O'Connor A, Jolly EE, Tugwell
P, Bedard M: Women's decisions about hormone replacement
therapy after education and bone densitometry.  CMAJ 1998,
159:1253-1257.
29. Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BH, Morrish
DW, Maksymowych WP, Steiner IP, Harley CH, Wirzba BJ, Hanley
DA, Blitz S, Russell AS: A controlled trial to increase detection
and treatment of osteoporosis in older patients with a wrist
fracture.  Ann Intern Med 2004, 141:366-373.
30. Majumdar SR, Johnson JA, Lier DA, Russell AS, Hanley DA, Blitz S,
Steiner IP, Maksymowych WP, Morrish DW, Holroyd BR, Rowe BH:
Persistence, reproducibility, and cost-effectiveness of an
intervention to improve the quality of osteoporosis care
after a fracture of the wrist: results of a controlled trial.  Oste-
oporos Int 2007, 18:261-270.
31. Fortin JM, Hirota LK, Bond BE, O'Connor AM, Col NF: Identifying
patient preferences for communicating risk estimates: a
descriptive pilot study.  BMC Med Inform Decis Mak 2001, 1:2.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2474/9/38/prepub